Young-Sook Song
Vorsitzender bei HANMI SCIENCE CO., LTD.
Vermögen: 216 Mio $ am 30.04.2024
Aktive Positionen von Young-Sook Song
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HANMI SCIENCE CO., LTD. | Vorsitzender | - | - |
| Vorstandsvorsitzender | - | 15.05.2024 | |
Beijing Hanmi Pharmaceutical Co., Ltd.
 Beijing Hanmi Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Hanmi Pharmaceutical Co., Ltd., Beijing Hanmi Pharmaceutical Co., Ltd. is a pharmaceutical company based in Beijing, CN. Beijing Hanmi Pharmaceutical Co. specializes in respiratory, pediatric, digestive, orthopedic, and anti-infective drugs, among others. The Chinese company also has research centers and development alliances. The company has a range of products, including probiotics for infants and young children, and medicine for respiratory diseases, cough, fever, and pain relief. The company is committed to social responsibility and has participated in various public welfare projects. The company was founded in 1996, and the CEO is Hai Long Ren. | Vorsitzender | - | - |
Karriereverlauf von Young-Sook Song
Ausbildung von Young-Sook Song
| Sookmyung Women's University | Undergraduate Degree |
Statistik
International
| Südkorea | 3 |
| China | 2 |
Operativ
| Chairman | 2 |
| Chief Executive Officer | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 2 |
| Health Technology | 2 |
| Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HANMI SCIENCE CO., LTD. | Distribution Services |
| Private Unternehmen | 1 |
|---|---|
Beijing Hanmi Pharmaceutical Co., Ltd.
Beijing Hanmi Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Hanmi Pharmaceutical Co., Ltd., Beijing Hanmi Pharmaceutical Co., Ltd. is a pharmaceutical company based in Beijing, CN. Beijing Hanmi Pharmaceutical Co. specializes in respiratory, pediatric, digestive, orthopedic, and anti-infective drugs, among others. The Chinese company also has research centers and development alliances. The company has a range of products, including probiotics for infants and young children, and medicine for respiratory diseases, cough, fever, and pain relief. The company is committed to social responsibility and has participated in various public welfare projects. The company was founded in 1996, and the CEO is Hai Long Ren. | Health Technology |
- Börse
- Insiders
- Young-Sook Song
- Erfahrung
